Dark

KRYS
Krystal Biotech, Inc. Common Stock
stock NASDAQ

At Close

Aug 1, 2025 3:59:38 PM EDT

157.05USD+2.067%(+3.18)576,352

0.00Bid 0.00Ask 0.00Spread

Pre-market

Aug 1, 2025 8:35:30 AM EDT

153.03USD-0.546%(-0.84)775

After-hours

Aug 1, 2025 4:26:30 PM EDT

160.70USD+2.324%(+3.65)1,542

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

4.54B

CEO

Krish S. Krishnan

Headquarters

Pittsburgh, Pennsylvania, USA

Industry

Biotechnology

Next Earnings

Aug 4, 2025 (2d)

XLV

KRYS Stats

Avg. Vol. 10 Day

313,735

Avg. Vol. 30 Day

347,129

Employees

Market Cap

4,544,606,417

Shares Out.

28,898,680

On/Off Exchange

59%/41%

6 Month Beta

0.79

1 Year Beta

0.96

2 Year Beta

0.96

3 Year Beta

0.93

52 Week Low

122.80

52 Week High

207.84

SMA50

140.35

SMA200

161.93

1 Week

+6.54%

1 Month

+11.26%

3 Month

-5.36%

6 Month

-1.11%

1 Year

-18.07%

2 Year

+24.53%

5 Year

+284.59%

Profile

krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that "nature operates in the shortest way possible". (aristotle)

KRYS Stock Summary

Krystal Biotech, Inc. Common Stock (NASDAQ:KRYS) stock price today is $157.05, and today's volume is 576,352. KRYS is up 2.067% today. The 30 day average volume is 347,129. KRYS market cap is 4.54B with 28,898,680 shares outstanding.